AlphaYouJS
Insider selling
J. Scott Garland sold $607K of Enliven Therapeutics, Inc. (ELVN) stock
J. Scott Garland, Dir of Enliven Therapeutics, Inc. (ELVN), sold 13,000 shares of ELVN stock worth $607K, per an SEC Form 4 filed Oct 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 1, 2026, 4 days before it was made public.
- Traded
- Oct 1, 2026
- Disclosed
- Oct 5, 2026
- Filing delay
- 4 days
- Role
- Dir
- Source
- SEC Form 4
More ELVN insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.